“…The administration of IMP prior to ischemia maintains a high concentration of IMP during ischemia. 25 In the present study, constant administration of IMP also resulted in a significant elevation of plasma IMP concentration (before IMP administration: 0.035 mmol/L, after IMP administration: 0.2 mmol/L, p< 0.05) and ameliorated neutrophil infiltration and reduced MPO activity and TNF-production in the lungs, with amelioration of decreased SpO2. We acknowledge the limitations of the present study because we did not evaluate the effects of AMPD inhibition and endogenous IMP production on the remote lung injury.…”